Journal article
92 Is SABR Cost-Effective in Oligometastatic Cancer? An Economic Analysis of SABR-COMET
Authors
Qu M; Chen Y; Zaric G; Senan S; Olson R; Harrow S; John-Baptiste A; Gaede S; Mulroy L; Schellenberg D
Journal
Radiotherapy and Oncology, Vol. 139, , pp. s41–s42
Publisher
Elsevier
Publication Date
October 2019
DOI
10.1016/s0167-8140(19)33384-5
ISSN
0167-8140